Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA panel supports Janssen’s esketamine nasal spray for depression

pharmaceutical-technologyFebruary 14, 2019

Tag: FDA , Janssen , Esketamine , depression

PharmaSources Customer Service